CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
methylphenidate +1 moredrug
Likely dose
methylphenidate 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02162381
NCT02162381N/ACompleted
CompareCT.gov

Methylphenidate Effect on Performing Humphrey Visual Fields

Rabin Medical Center·interventional·Posted Jun 12, 2014·Updated Apr 11, 2018

In Brief

A clinical study evaluating methylphenidate and guidance for Visual Field Tests. Completed, enrolled 32 participants across 1 site.

Detailed Summary

Study will include adults with abnormal visual fields. Half of them will be given either methylphenidate 10mg 2 hours before repeating the visual field test. the rest will serve as controls. All Subjects will also have a complete eye examination, a short questionnaire and a questionnaire to screen for attention deficit disorder. The investigators will compare the visual field results between the 2 tests.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Field Tests
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 12, 2014
Enrollment StartJun 1, 2014
Primary CompletionApr 10, 2018
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 12.1 years ago

Interventions

methylphenidatedrug

a single dose of methylphenidate 10 mg to be taken orally in the morning

guidanceother

subjects will be given an explanation and advice about how to perform well in visual field testing